APA

Bornhäuser M., Illmer T., Le Coutre P., Pursche J., von Bonin M., Freiberg-Richter J., Schaich M., Platzbecker U., Thiede C., Ottmann O. G., Köhne C., Braess J., Ehninger G. & Schleyer E. (20040630). Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells. : Annals of hematology.

Chicago

Bornhäuser M, Illmer T, Le Coutre P, Pursche J, von Bonin M, Freiberg-Richter J, Schaich M, Platzbecker U, Thiede C, Ottmann O G, Köhne Ch, Braess J, Ehninger G and Schleyer E. 20040630. Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells. : Annals of hematology.

Harvard

Bornhäuser M., Illmer T., Le Coutre P., Pursche J., von Bonin M., Freiberg-Richter J., Schaich M., Platzbecker U., Thiede C., Ottmann O. G., Köhne C., Braess J., Ehninger G. and Schleyer E. (20040630). Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells. : Annals of hematology.

MLA

Bornhäuser M, Illmer T, Le Coutre P, Pursche J, von Bonin M, Freiberg-Richter J, Schaich M, Platzbecker U, Thiede C, Ottmann O G, Köhne Ch, Braess J, Ehninger G and Schleyer E. Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells. : Annals of hematology. 20040630.